Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BDKRB1 | P46663 | 13/20 | 0.39 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.35 |
| ▸ | CDK2 | P24941 | 1/20 | 0.35 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.35 |
| ▸ | CRHR1 | P34998 | 2/20 | 0.34 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.33 |
| ▸ | XIAP | P98170 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14084953 | 0.90 | BDKRB1 (0.42) | BDKRB1CCNA2CDK2CCNA1CRHR1 | |
| SCHEMBL4701105 | 0.89 | CCKBR (0.40) | BDKRB1CCNA2CDK2CCNA1RIPK1 | |
| SCHEMBL4702034 | 0.84 | BDKRB1 (0.42) | BDKRB1CCNA2CDK2CCNA1 | |
| SCHEMBL4705613 | 0.83 | BDKRB1 (0.43) | BDKRB1CCNA2CDK2CCNA1 | |
| SCHEMBL4703604 | 0.83 | BDKRB1 (0.39) | BDKRB1CCNA2CDK2CCNA1 | |
| SCHEMBL4703537 | 0.81 | BDKRB1 (0.44) | BDKRB1CCNA2CDK2CCNA1 | |
| SCHEMBL4701827 | 0.81 | BDKRB1 (0.43) | BDKRB1CCNA2CDK2CCNA1 | |
| SCHEMBL4705710 | 0.80 | BDKRB1 (0.46) | BDKRB1CCNA2CDK2CCNA1 | |
| SCHEMBL4702448 | 0.80 | BDKRB1 (0.46) | BDKRB1CCNA2CDK2CCNA1 | |
| SCHEMBL4790056 | 0.79 | RIPK1 (0.45) | RIPK1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1633348-B1 | 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | ELAN PHARM INC (US) | 2008-10-08 | — | — | EP | claimed |